Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Millennium Pharmaceuticals, Inc.
Scientific Title
A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)